emergentec biodevelopment GmbH

emergentec biodevelopment GmbH (Emergentec) is a privately-held biotechnology company, engaged in provision of various technologies and competencies in the area of life sciences IT, data management, Omics data generation and analysis, protein structure analysis and antigenicity screening, as well as statistics and data mining. The company drives product development of novel diagnostics and therapeutics in areas with evident medical need such as cancer, infectious diseases, autoimmune disorders, and organ transplantation. Emergentec has a dedicated research and development department focused on discovery and evaluation of biomarkers and targets. The company operates on its proprietary in-silico discovery platform in which heterogeneous Omics data is used as input and the output is protein biomarker / target candidates. Emergentec is headquartered in Vienna, Austria.

Street: 
Rathausstrasse 5/3
City: 
Vienna
Postcode: 
1010
Federal State : 
Austria
WebSite: 
www.emergentec.com
Fax: 
43-1-4034966

Company Index Score

Current Index Score Historical Index Score
  • emergentec biodevelopment GmbH currently scores 50 % in the index.
  • emergentec biodevelopment GmbH is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • emergentec biodevelopment GmbH is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets